Humira biosimilars set the stage for long-awaited 2023 US launches
Pharmaceutical Technology
DECEMBER 4, 2022
For example, the first-to-market status was beneficial when it came to insulin biosimilars. Biosimilars with this designation are beneficial to payers as they eliminate the need for another prescription, she explains An interchangeable biosimilar can be automatically substituted for Humira at a pharmacy, Bhat adds.
262 
Let's personalize your content